As an innovation company with the mission “Bayer: Science For A Better Life,” Bayer focuses on its core competencies in developing new solutions for the fast-growing, innovation-driven areas of health care, agriculture and high-tech materials. Based on this innovation capability and other core competencies, we are pursuing a value-creating strategy of sustainable and profitable growth in our businesses. In doing so we consistently exploit both organic and external growth opportunities while at the same time optimizing structures and processes and improving our cost base.
Portfolio: We plan to continue playing leading roles in attractive markets and to steadily expand the strong positions we already hold, placing special emphasis on the development of our life-science businesses. We also aim to leverage research synergies by gaining a better understanding of human, animal and plant biology. In MaterialScience, we intend to defend our market position through leading-edge process technologies. Investments in capacity expansions and new facilities are creating economies of scale and cost leadership that will help to strengthen our position and our profitability.
Growth: We are systematically investing in our innovation capabilities and maximizing the value of our research and development pipeline and our technological expertise. We are also taking advantage of opportunities in the emerging markets.
Productivity: Based on the maxim “More innovation – less administration,” we are continuing our efforts to improve efficiency and simplify structures and processes throughout the Bayer Group.
You are leaving the Bayer AG website.
Bayer AG is not responsible for the information on the website to which you are linking.
